[Congenital familial endocardial fibroelastosis]. 1968

A A Tsil'man

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D004695 Endocardial Fibroelastosis A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis. Endomyocardial Fibroelastosis,Endocardial Fibroelastoses,Fibroelastoses, Endocardial,Fibroelastosis, Endocardial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A A Tsil'man
April 1967, The Journal of pediatrics,
A A Tsil'man
May 1954, Orvosi hetilap,
A A Tsil'man
December 1953, Nordisk medicin,
A A Tsil'man
February 1970, Kardiologiia,
A A Tsil'man
September 1972, Indian journal of pediatrics,
A A Tsil'man
July 1958, The Grace Hospital bulletin,
A A Tsil'man
January 1979, Nihon rinsho. Japanese journal of clinical medicine,
A A Tsil'man
May 1986, Clinical pediatrics,
A A Tsil'man
December 1970, Archives of disease in childhood,
Copied contents to your clipboard!